Pneumatic Nebulizers Market Is Predicted to Reach US$ 850.4 Million by 2027

Global sales of pneumatic nebulizers are expected to increase steadily at a CAGR of 4%, from a market valuation of US$ 699 million in 2022 to US$ 850.4 million by 2027. Sales of breath-actuated nebulizers are anticipated to expand at a similar CAGR of 4% during the next five years; this can be attributed to their benefits such as increased drug delivery capacity and decreased dose wastage.

A pneumatic nebulizer creates a negative pressure zone by delivering compressed gas through a jet-like structured device. The substance to be aerosolized is sheared into a liquid film after being entrained into the gas stream. Surface tension forces lead this film to become unstable and separate into droplets.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.factmr.com/connectus/sample?flag=S&rep_id=7716?PJ

𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗙𝘂𝘁𝘂𝗿𝗲 𝗧𝗿𝗲𝗻𝗱𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗻𝗲𝘂𝗺𝗮𝘁𝗶𝗰 𝗡𝗲𝗯𝘂𝗹𝗶𝘇𝗲𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁:

Looking ahead, the pneumatic nebulizers market is likely to witness several trends:

Personalized Medicine and Inhalation Therapy: Advances in personalized medicine may lead to tailored inhalation therapies, with pneumatic nebulizers playing a role in delivering customized medication formulations based on individual patient needs.

Smart Nebulizers and IoT Integration: The integration of smart features and Internet of Things (IoT) connectivity in pneumatic nebulizers will likely increase. This includes real-time monitoring of device usage, medication adherence, and seamless data transfer to healthcare providers for improved patient management.

Nanotechnology Applications: Innovations in nanotechnology may influence the development of nebulizers with improved drug delivery efficiency and targeted delivery to specific areas of the respiratory system, enhancing therapeutic outcomes.

Expansion in Emerging Markets: The growing awareness of respiratory health in emerging markets, coupled with increasing healthcare infrastructure, may drive the expansion of the pneumatic nebulizers market in regions with previously untapped potential.

Collaborations and Partnerships: Collaborations between device manufacturers, pharmaceutical companies, and technology firms may lead to synergies in the development of integrated solutions, combining advanced medications with state-of-the-art pneumatic nebulizer technologies.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

Omron Corp., PARI Pharma, General Electric Company, Allied Healthcare Products, Inc., Becton, Dickinson & Company, and GF Health Products, Inc. are some of the top companies in the pneumatic nebulizers market.

The market for pneumatic nebulizers is also progressing due to the presence of significant companies. However, the development of highly advanced mesh nebulizers has opened up numerous potential for the manufacturers of pneumatic nebulizers.

Mesh nebulizers are another tool used widely by pharmaceutical corporations in drug research.

• For instance, mesh nebulizers rather than jet nebulizers are more frequently used in clinical trials supported by pharmaceutical corporations, according to a review of clinical trial databases from the United States and Europe.

The market is further distinguished by a sizable share of small producers in emerging countries who concentrate on creating relatively less expensive nebulizer products.

• The launch of the OMRON NE C106 was announced in July 2020 by OMRON Healthcare, the top Japanese provider of home healthcare. It is a supplement to their line of compressor nebulizers. The distribution of respiratory medications is an area in which the company is constantly evolving.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝 :

• Koninklijke Philips N.V.
• Omron Corp.
• PARI Pharma
• General Electric Company
• Allied Healthcare Products, Inc.
• Becton, Dickinson & Company
• GF Health Products, Inc.
• Medline Industries, Inc.
• Briggs Healthcare
• Vectura Group Plc

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐏𝐧𝐞𝐮𝐦𝐚𝐭𝐢𝐜 𝐍𝐞𝐛𝐮𝐥𝐢𝐳𝐞𝐫𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

• 𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗧𝘆𝗽𝗲 :
• Vented
• Breath-actuated

• 𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿 :
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

• 𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻 :
• North America
• Latin America
• Europe
• East Asia
• South Asia & Oceania
• MEA

𝗞𝗲𝘆 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗣𝗻𝗲𝘂𝗺𝗮𝘁𝗶𝗰 𝗡𝗲𝗯𝘂𝗹𝗶𝘇𝗲𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁:

𝗣𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝗰𝗲 𝗼𝗳 𝗥𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀: The increasing prevalence of respiratory disorders globally, coupled with the rising incidence of conditions like asthma and COPD, is a significant driver for the pneumatic nebulizers market. These devices offer an effective and convenient way to administer medication directly to the lungs.

𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗡𝗲𝗯𝘂𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: Ongoing advancements in nebulization technology, including improvements in aerosol particle size distribution and drug delivery efficiency, contribute to the market growth. Manufacturers are focusing on enhancing the performance and usability of pneumatic nebulizers.

𝗥𝗶𝘀𝗲 𝗶𝗻 𝗚𝗲𝗿𝗶𝗮𝘁𝗿𝗶𝗰 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻: The aging global population is more susceptible to respiratory conditions, leading to a growing demand for respiratory care devices. Pneumatic nebulizers cater to the needs of elderly individuals who may face challenges using other inhalation devices.

𝗛𝗼𝗺𝗲 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗮𝗻𝗱 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗼𝗻𝘃𝗲𝗻𝗶𝗲𝗻𝗰𝗲: The trend toward home healthcare and patient-centric treatment options has increased the demand for portable and user-friendly nebulizers. Pneumatic nebulizers, with their ease of use, are well-suited for home-based respiratory therapy.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭

• Based on product type, the breath-actuated segment held significant market share in 2021. Pneumatic nebulizers that are breathed into have a greater capacity for medicine administration and reduce dosage waste. Consequently, these offer advanced inhalation therapy, which results in the segment's leading position in the market.

• In terms of application, the COPD segment dominated the global market in 2021. As the condition progresses, breathing becomes more challenging since it is a progressive condition. Respiratory failure, which could be life-threatening, could result from severe COPD. Hence, individuals with COPD are increasingly in need of pneumatic nebulizers.

• In terms of end-user, the home healthcare segment accounted for the largest market share globally in 2021. Self-medication is made possible by pneumatic nebulizers, which could lessen the need for hospitalization and prevent the spread of illnesses.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:https://www.factmr.com/connectus/sample?flag=RC&rep_id=7716?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.